Drug Type Small molecule drug |
Synonyms GNE 3500, GNE3500 |
Target |
Action inverse agonists |
Mechanism RORG inverse agonists(Nuclear receptor ROR-gamma inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H30FN3O3S |
InChIKeyWLCIIQPUMOJJOF-MHECFPHRSA-N |
CAS Registry1537859-24-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | United States | 23 Jun 2015 |